ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Masaaki Kato
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kato, M.
Right arrow Articles by Ohnishi, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kato, M.
Right arrow Articles by Ohnishi, K.

Ann Thorac Surg 1995;59:908-914
© 1995 The Society of Thoracic Surgeons

Experimental Assessment of Newly Devised Transcatheter Stent-Graft for Aortic Dissection

Masaaki Kato, MD, Takehisa Matsuda, PhD, Mitsunori Kaneko, MD, Takashi Ueda, MD, Toru Kuratani, MD, Yasuhiko Yoshioka, MD, Kenji Ohnishi, MD

Division of Cardiovascular Surgery, Osaka Prefectural Hospital, and Department of Bioengineering, National Cardiovascular Center Research Institute, Osaka, Japan

Accepted for publication November 7, 1994.


    Abstract
 Top
 Footnotes
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 Acknowledgments
 References
 
Despite recent advances, surgical results for Stanford type B dissection are not yet satisfactory because the procedure is so highly invasive. The aim of this study was to devise a new intraaortic (IA) graft that would offer less invasive treatment for type B dissection. To close the entry of type B dissections using transcatheter placement, we devised an IA graft (inner diameter, 15--20 mm; length, 40 to 60 mm) in which a self-expandable stent was covered with a thin, open-cell--structured polyurethane jacket. In acute animal experiments in which type B aortic dissections were prepared in 4 mongrel dogs, IA grafts were implanted to close the entry using a transfemoral catheter sheath, and closure of all the entries was confirmed by aortography. In chronic experiments, five IA grafts for normal descending aortas and one IA graft for an experimentally dissected aorta were implanted to observe histologic biocompatibility for up to 8 months. Histopathologic examination conducted at the projected sacrifice periods revealed that endothelialization of the luminal surface of the IA graft had begun as early as 1 month after implantation and was completed within 4 months. The prototype device that we developed may be promising as an effective, minimally invasive therapeutic intervention for closure of the entry site of type B dissection.


    Introduction
 Top
 Footnotes
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 Acknowledgments
 References
 
See also page 914.

Acute aortic dissection is a life-threatening condition [1, 2]. Surgical intervention for type B dissection has not provided satisfactory results [37] because of the advanced age of patients at onset [8, 9] and the high incidence of postoperative pulmonary complications accompanying lateral thoracotomy [3, 5, 6, 8, 9]. It has been argued that medical treatment is superior to surgical treatment in acute type B dissection [24, 7, 10, 11]. However, in 20% to 50% of patients who have survived the acute stage with medical treatment, enlarged aneurysms develop within 1 to 5 years of onset [2, 3, 11]. In addition, in chronic type B dissection, distinct enlargement of the false lumen and narrowing of the true lumen occur in most cases, making surgical treatment at a later stage more difficult [12].

Thus, it is necessary to develop a less invasive therapeutic procedure to treat the type B dissection at an acute or subacute stage. Recently, intraluminal devices have been developed that may conceivably cure aortic dissection [13, 14]. These devices are designed to pressure the inner dissected wall from the aortic true lumen, and subsequently to cure the diseased vessel. These are metallic intravascular stents that are expanded by balloon or self-expand by their own elasticity.

In this article, we report on a transcatheter-placed, self-expandable intraaortic (IA) graft that we developed to accomplish less invasive obliteration of aortic dissection. Our IA graft consists of a tandem-type Gianturco stent with an outer jacket of thin, microporous polyurethane. The effectiveness and safety of this new graft and the vascular tissue regeneration process associated with the implanted graft were examined in acute and chronic phases.


    Material and Methods
 Top
 Footnotes
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 Acknowledgments
 References
 
Concept of Transcatheter Closure of Entry Site
Figure 1Go shows our concept of transcatheter treatment for type B dissection. The dissection into a true and a false lumen is shown in Figure 1AGo. A catheter sheath, inserted through the femoral artery, is positioned slightly proximal to the entry site of the dissection (Fig 1BGo). A compressed IA graft is inserted into the catheter sheath and pushed out at the entry site. The graft expands in the vascular lumen as a result of the decompression of the stent and concomitantly attaches to the aortic intima, resulting in the closure of the entry site (Fig 1CGo). The true lumen thrusts aside the false lumen, where sooner or later a thrombus is formed.



View larger version (34K):
[in this window]
[in a new window]
 
Fig 1. . Catheter-aided treatment of type B dissection. (A) Type B dissection. (B) A catheter sheath bearing the compressed graft is inserted from the femoral artery into the true lumen. (C) The intraaortic (IA) graft expands in the vascular lumen, resulting in closure of the entry site.

 
In our implementation of this concept, we devised and developed a compressible and self-expandable graft. Such an IA graft must fulfill the following requirements: (1) the graft can be inserted into a catheter by compression and expanded in a vascular lumen by decompression, (2) the materials for fabrication of the graft are elastic and durable, and (3) a biocompatible surface is essential to promote neointimal tissue formation.

To meet the first requirement, we used a self-expandable stent as the structural support of the graft. To meet the second and third requirements, we selected segmented polyurethane, the most durable and elastic material among the existing synthetic elastomers, as a material for a thin-wall graft which outer-jackets the stent. To promote tissue regeneration and ensure a nonthrombogenic potential similar to the native artery in the chronic phase, microporous structure was impregnated into a graft.

Preparation of IA Graft
A self-expandable stent (a Gianturco-type stent known as the Z-stent; William Cook Europe A/S, Bjaeverskov, Denmark) and a porous polyurethane jacket were prepared separately and these were then assembled into a one-piece graft.

POROUS POLYURETHANE JACKET.
A segmented polyurethane, Cardiomat 610 (Kontron Inc, Everett, MA), was used for fabrication of the graft. Crystals of sodium chloride (mean granular size, 0.1 mm) were mixed with 5% tetrahydrofuran solution of polyurethane. After the crystal-impregnated solution was cast in a cylindrical vessel by a rotation method at room temperature, impregnated crystals were eluted by washing with warm water to form an open-cell-structured, microporous polyurethane jacket (wall thickness, 0.2 mm; average pore size, 0.1 mm). Jackets with diameters of 12, 15, and 19 mm were prepared and their lengths were adjusted to the stent lengths. The luminal and external surfaces and the cross-section of porous polyurethane jacket were examined by a scanning electron microscope (Hitachi S-400; Hitachi Co Ltd, Tokyo, Japan).

STENT.
The device consisted of two or three self-expandable Gianturco stents connected in tandem with two stainless steel struts. Each stent was constructed of 0.35 mm stainless steel wire (Nippon Seisen Co Ltd, Osaka, Japan) bent into a nine-tip zigzag configuration that was 2 cm long and had an internal diameter of 15 or 20 mm (full length, 40 mm or 60 mm).

FABRICATION OF ONE-PIECE GRAFT.
The tetrahydrofuran solution of polyurethane was used as a glue to attach the stent to the porous polyurethane jacket as follows. The expanded form of the stent was inserted into the porous polyurethane jacket, and drops of solution were applied to the respective bending points of the stent and then air-dried. A structural support with two stents was covered with polyurethane jackets in full length (40 mm), and a support with three stents was covered only in proximal two stents (covered length, 40 mm; uncovered length, 20 mm). A 15-mm--diameter stent was used for a 12-mm--diameter graft, and a 20-mm--diameter stent was used for a 15-mm or 19-mm--diameter graft. The fabricated grafts were compressed by hand and inserted into a 12F catheter sheath.

In Vivo Performance
Ten adult mongrel dogs (body weight, 14 to 18 kg) were anesthetized and maintained under anesthesia with Nembutal (Abbott, Abbott Park, IL; pentobarbital sodium, 4 mg/kg). Mechanical ventilation was performed for dogs subjected to the experimental type B dissection. All animals were handled in compliance with the Principles of Laboratory Animal Care formulated by the National Society for Medical Research (USA) and the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health (NIH publication 85-23, revised 1985).

PREPARATION OF EXPERIMENTAL DISSECTION.
After systemic heparinization the descending aorta exposed by left lateral thoracotomy was simply clamped and a transverse incision was made in the adventitia. The aorta then was dissected semicircularly between the intima and adventitia and the resultant flap was separated toward the distal side using a special spatula. A reentry site was made at about 10 to 15 cm distal to the incision (the intima was punctured by a probe). Next, an entry site was made at the intima of the incision site using a 6-mm punch. After the dissected adventitia was sutured, the aorta was unclamped to complete the experimental dissection.

IA GRAFT IMPLANTATION.
After the entry site and false lumen were confirmed by aortography, the position of the entry site was marked on the body surface. A 12F catheter sheath (William Cook Europe A/S, Bjaeverskov, Denmark) inserted through the femoral artery was positioned at the entry site of the true lumen. After an IA graft was delivered up to the site of the entry through the catheter sheath using a pushing rod (William Cook Europe A/S), the graft was expanded from the sheath into the aorta by pulling the sheath without moving the push rod. On the basis of the preliminary aortogram study, the size of IA graft was selected to be 20% to 30% larger than the aortic diameter at the proximal side of the dissection. For acute experiment, 4 animals were sacrificed 2 hours after implantation. For chronic experiment, implantation was performed on 5 adult mongrel dogs that had normal descending aortas and 1 dog that had been subjected to experimental type B dissection prepared 3 weeks before implantation.

HISTOLOGIC EXAMINATION.
At the projected sacrifice periods, the entire graft complex and adjacent segments of aorta were excised. Each specimen was divided into three parts: proximal junction, middle portion, and distal junction. Each of the three parts was further divided into two parts, one for light microscopic examination, the other for electron microscopic examination. Specimens for light microscopic examination were immersed in 10% neutral buffered Formalin, and stained by hematoxylin and eosin, azan Mallory, elastica van Gieson, and peroxidase-antiperoxidase methods. The specimens for electron microscopic examination were fixed in a 3% solution of glutaraldehyde (0.1 mol/L cacodylic acid buffer solution, pH 7.2) for 2 hours at room temperature, after which the specimens were dehydrated using 1% tannic acid and an alcohol series method. After critical-point drying, the specimens were subjected to vapor deposition of platinum palladium (Polaron, scanning electron microscopy coating system) and then examined with scanning electron microscopy.


    Results
 Top
 Footnotes
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 Acknowledgments
 References
 
Intraluminal Aortic Graft
The finished form of the IA graft with two self-expandable metallic stents is shown in the right side of Figure 2Go. A tandem-type Gianturco stent (shown in the left side of Figure 2Go) had an outer jacket composed of the microporous polyurethane film. Both the stent and the porous polyurethane film, which were securely glued to each other, were elastic enough to be compressed into the form of a bar. The compressed graft, easily insertable into a 12F catheter sheath (inner diameter, 4 mm) was expanded to 15 to 20 mm upon decompression, depending on the size of the Gianturco stent used. Scanning electron microscopic examination of the porous polyurethane jacket showed that the luminal surface possessed numerous micropores that were approximately 100 to 150 µm in diameter (Fig 3Go). In the IA graft with three stents, only proximal two stents were layered with polyurethane microporous membrane.



View larger version (147K):
[in this window]
[in a new window]
 
Fig 2. . (Left) Gianturco stent (double-tandem type), which can be inserted into the 8F catheter sheath. (Right) Finished form of the intraaortic graft, which can be inserted into the 12F catheter sheath.

 


View larger version (135K):
[in this window]
[in a new window]
 
Fig 3. . Cross-section of the porous polyurethane film that covered the stent. Open-cell--structured graft wall approximately 150 to 200 µm in thickness and micropores approximately 100 to 150 µm in diameter were observed (original magnification x100).

 
IA Graft Implantation and Closure of Entry Site
Totally, 10 IA grafts were implanted. Five IA grafts were implanted into mongrel dogs in which double-barrel artificial aortic type B dissection was experimentally created. Of these, four grafts were removed at 2 hours after entry closure, and the remaining one was removed at 8 months. Another five grafts were implanted in dogs without experimental dissection. These were removed at 1 month (n = 1), 4 months (n = 2), and 6 months (n = 2).

Aortography clearly revealed that entry sites and false lumens were created in the descending aorta of all the experimentally dissected animals (Fig 4AGo). Grafting at entry sites was attained in all cases (Figs 4B, 4CGoGo); neither jumping at the time of grafting nor migration after grafting was observed. Aortograms at 30 minutes after the implantation revealed that the entry site was fully closed in all cases, whereas the false lumen was partly visualized retrogradely from the reentry (see Fig 4CGo). Cineangiography displayed elastic motion of the graft in synchrony with aortic pulsation.



View larger version (115K):
[in this window]
[in a new window]
 
Fig 4. . Aortograms of intraaortic (IA) graft in acute phase. (A) Experimentally created double-barrel-type dissection was clearly observed in the descending aorta (F = false lumen; T = true lumen.) (B) The intraaortic graft (IA graft) was compressed into the 12F catheter sheath and then transported intraluminally to the aneurysmal entry site (E) of the descending aorta by a push rod. (C) The entry site was completely closed by the IA graft 30 minutes after implantation. False lumen was partly visualized retrogradely as a result of blood flow from the reentry.

 
The vessel segment with implanted IA graft was removed 2 hours after implantation; the entry site was filled with thrombus formed, and in the part of the dissection where the false lumen was pressed by the IA graft, thrombi was formed. However, little thrombus formation was observed in the distal part of the false lumen or at the reentry site at this period, probably due to systemic heparinization.

Aortography showed that no migration took place in any of the animals in chronic phase. In animals with experimentally created dissection, the false lumen was completely obliterated 8 months after implantation.

Tissue Regeneration
Six IA grafts, five of which were implanted in normal descending aortas and the remaining one that was in an experimentally dissected aorta, were histologically examined as to how tissue regeneration proceeded after graft implantation. The vessel segments were removed at 1, 4, 6, and 8 months. Little complication (such as necrosis) was observed in any of explanted samples.

On gross examination at 1 month after implantation, minimal gross thrombus formation was observed on the luminal surface, most of which was covered with a thin, yellowish-white membrane. A small number of tiny thrombi were present on the distal portion of the graft. At 6 months (Fig 5AGo), there was no thrombus on the IA graft, which was totally covered with a yellowish-white uniform tissue that resembled vascular endothelium. In the luminal surface of the dissected aorta removed at 8 months, the entry site was closed and the false lumen was completely filled with clot (Fig 5BGo). A thrombotic layer was observed between the intima and the adventitia of experimentally created vessel wall.



View larger version (180K):
[in this window]
[in a new window]
 
Fig 5. . Gross luminal appearances. (A) Six months after implantation, the luminal surface was covered with yellowish-white membrane. (B) Eight months after implantation, the false lumen was completely clotted by the intraaortic graft, and a thrombotic layer was observed between the intima and the adventitia.

 
On microscopic examination, little infiltration of inflammatory cells except for a small number of foreign-body giant cells was observed around the polyurethane graft up to 4 months. At this period, the luminal surface of the graft was covered with a monolayer of endothelioid cells; this was verified by detection of factor VIII antigen by peroxidase-antiperoxidase staining (Fig 6AGo). Collagen fibers were present in the vicinity of the polyurethane and within open-cell-structured micropores. Regenerated elastic fibers were observed in the newly formed intima (Fig 6BGo).



View larger version (120K):
[in this window]
[in a new window]
 
Fig 6. . (A) Light micrograph stained by peroxidase-antiperoxidase method (original magnification, x400) from middle portion of the intraaortic graft at 4 months. Black-stained cells that cover the graft were identified as endothelial cells. (B) Light micrograph stained with elastica van Gieson (original magnification, x400) from proximal portion of the intraaortic graft of the same sample. (PU = polyurethane.)

 
Scanning electron micrographs showed that, at 1 month, the graft was covered extensively by adherent and proliferating endothelial cells and partly by some blood components (neutrophils, platelets, and fibrin) at nonendothelialized regions (Fig 7AGo). In a graft removed after 4 months (Fig 7BGo), endothelial cells were present over the entire luminal surface, and a layer composed of dense connective tissue and mesenchymal cells was present beneath the endothelial cells. This indicates that the formation of new intima was completed within this period. A cross-section of the graft showed that the newly formed intima was composed of a uniform layer of 0.15 mm in thickness. There was no evidence of thinning of the aortic wall due to pressure. At 6 months, many newly formed capillaries that had ingrown through open-cell--structured micropores were observed at luminal surfaces (Fig 7CGo).




View larger version (242K):
[in this window]
[in a new window]
 
Fig 7. . (A) Scanning electron micrograph of the luminal surface of an intraaortic graft removed 1 month after implantation (original magnification, x2,000). The graft is extensively covered by adherent, proliferating endothelial cells (EC) and some blood components (neutrophils, platelets, and fibrin) attached to portions of the surface (upper left). (B) A cross-sectional scanning electron micrograph of the graft and descending aorta removed 4 months after implantation (original magnification, x40) showing that a newly formed intima (NI) was composed of a uniform layer 0.15 mm in thickness. There is no evidence of thinning of the aortic wall due to pressure. (PU = polyurethane.) (C) Scanning electron micrograph of the surface of a graft removed 6 months after implantation (original magnification, x500) showing the smooth luminal surface covered with EC and newly formed capillaries (NC) that had grown in through micropores.

 

    Comment
 Top
 Footnotes
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 Acknowledgments
 References
 
The primary objective of surgical treatment for type B dissection is to close the entry site in the thorax. The standard surgical methods include graft replacement of the descending aorta including the entry site [5, 10] and entry site repair with aneurysmorrhaphy [15]. The success rate of these operations in type B dissections is not satisfactory [37]. Taking into consideration that the average age of patients with type B dissection is increasing, the development of a minimally invasive therapeutic procedure for entry site closure is in strong demand.

Percutaneous transluminal angioplasty for atherosclerotic vascular disease has led to percutaneously implantable intraluminal devices which are either self-expandable or balloon-expandable [1619]. Catheter-aided methods based on these devices have been studied in recent years to develop new, minimally invasive techniques for treatment of type B dissection [13, 14, 20]. In 1986, Akaba and associates [20] devised a cylinder-type balloon catheter that was used for intraluminal compression of a dissection that had been induced by an inflated balloon. A metallic stent was later developed and introduced to prevent re-narrowing of the peripheral artery and the biliary tract after procedures were performed to dilate their lumens [1619]. These metallic stents were used not only for preventing stenosis of peripheral blood vessels and coronary arteries, but also for maintaining the true lumen and the closure of the false lumen in aortic dissection [13, 14]. Recently developed balloon-expandable stents for curing aortic dissection include the Trent stent [13], Palmaz stent [14], and Fontaine stent [14]. These intraluminal devices successfully induce clot formation as a result of compression at the false lumen of experimentally created aortic dissection. Due to the very nature of their design, however, rapid obliteration at entry site would not be expected and furthermore incomplete obliteration may occur.

We developed a new graft especially for treatment of acute type B dissection by covering a Gianturco stent, a typical self-expandable stent, with an elastomeric polyurethane jacket. We expect that its elasticity should make it function well not only at the time of insertion into the sheath and expansion in the lumen, but also during the chronic phase, so that it provides a constant pressure against the false lumen. We fabricated three different sizes of IA grafts with microporous segmented polyurethane. This material, extensively used for blood pumps such as intraaortic balloon pumps, assist devices, and artificial hearts, is elastic and durable. This microporous film is much more flexible than a nonporous film; it is so compressible that an IA graft can be inserted easily into a catheter sheath. In addition, the open-cell structure was designed to enhance tissue regeneration on and through the porous jacket.

We consider the diameter of the IA graft relative to that of the dissected aorta to be very critical. An oversized graft may result in pressure necrosis of the aortic wall, whereas an undersized graft may lead to graft migration. In this study, the diameter of the implanted IA graft was set at 120% to 130% of the diameter of the normal segment of the aorta proximal to the dissection. In all animal subjects, the IA graft was placed successfully in the predesignated part of the aorta, and closed the entry site of the dissection. Autopsy at 2 hours after implantation showed that the IA graft stretched tightly against the intima of the aortic wall and that blood was already coagulated in the false lumen, which was under stent pressure. Observations for up to 8 months revealed no thinning or pressure necrosis of the aortic wall, and no migration of the graft. Our selected proportions, therefore, seem to be appropriate for application in clinical cases. Although our IA grafts did not have any hooks to prevent migration, structural modification of stents to include hooks could greatly guarantee the stabilization of implanted grafts.

The tissue regeneration process on the IA graft, assessed by light and electron microscopic evaluation, was extremely encouraging. Endothelialization, probably initiated by ingrowth through micropores, began within several weeks. At 4 months, the entire surface of the IA graft was endothelialized, and micropores were filled with regenerated collagen fibers. In addition, the elastic fiber was regenerated. Fewer foreign-body giant cells were observed 6 months after implantation, indicating that tissue regeneration was completed within this period. Neovascularization also occurred beneath the endothelial layer through transinterstitial micropores. Thus, the microporous structure of segmented polyurethane film seems to enhance the tissue regeneration potential with minimal foreign-body reaction.

The essential requirement of this IA graft therapy is to close the entry point, which requires precise diagnosis of the entry site. In addition to aortograms used in this study, intravascular echography, magnetic resonance imaging spectroscopy, and other diagnostic techniques may help to precisely position IA grafts. Our current device uses a self-expandable Z-stent, which cannot adapt itself to a curved part of the aorta. This hampers application of the IA graft to the segment of the aorta immediately distal to the left subclavian artery, which is the most common site of the entry of type B dissection. Extended application to these dissections will require further modification of the IA graft. And as for the application of our IA graft to aneurysmal diseases, we think it is necessary to modify the covering material because our extremely elastic covering jacket may be the cause of graft aneurysm formation after implantation.

In summary, we developed a novel intraaortic prosthesis composed of a Gianturco stent and a microporous segmented polyurethane jacket, and successfully closed off the entry site of experimentally prepared type B dissection using the transcatheter technique. These results in dogs, together with satisfactory histologic biocompatibility in chronic experiments, suggest that our IA graft may be effective in treating the acute stage of type B dissection with minimal invasion.


    Acknowledgments
 Top
 Footnotes
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 Acknowledgments
 References
 
We are grateful to Dr Shigeko Takaichi and Dr Kiyoshi Kotoh for their excellent assistance in scanning electron and light microscopic examinations. Doctor Masaaki Kato highly appreciates the continuous advice and encouragement of Professor Hikaru Matsuda, First Department of Surgery, Osaka University Medical School.


    Footnotes
 Top
 Footnotes
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 Acknowledgments
 References
 
Address reprint requests to Dr Kato, Division of Cardiovascular Surgery, Osaka Prefectural Hospital, 3-1-56 Mandai-higashi, Sumiyoshiku, Osaka 558, Japan.


    References
 Top
 Footnotes
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 Acknowledgments
 References
 

  1. Bickerstaff LK, Pairolero PC, Hollier LH, Melton LJ, Peenen HJV, Cherry KJ. Thoracic aortic aneurysms: a population-based study. Surgery 1982;92:1103–8.[Medline]
  2. Anagnostopoulos CE, Prabhakar MJS, Kittle CF. Aortic dissections and dissecting aneurysms. Am J Cardiol 1972;30:263–73.[Medline]
  3. Doroghazi RM, Slater EE, DeSanctis RW, Buckley MJ, Austen WG, Rosenthal S. Long-term survival of patients with treated aortic dissection. J Am Coll Cardiol 1984;3:1026–34.[Abstract]
  4. Elefteriades JA, Hartleroad J, Gusberg RJ, et al. Long-term experience with descending aortic dissection: the complication-specific approach. Ann Thorac Surg 1992;53:11–21.[Abstract]
  5. Miller DC, Stinson EB, Shumway NE. Realistic expectations of surgical treatment of aortic dissections: the Stanford experience. World J Surg 1980;4:571–81.[Medline]
  6. Miller DC, Stinson EB, Oyer PE, et al. Operative treatment of aortic dissection: experience with 125 patients over a 16 year period. J Thorac Cardiovasc Surg 1979;78:365–82.[Abstract]
  7. Jex RK, Schaff HV, Piehler JM, et al. Early and late results following repair of dissections of the descending thoracic aorta. J Vasc Surg 1986;3:226–37.[Medline]
  8. Miller DC, Mitchell RS, Oyer PE, Stinson EB, Jamieson SW, Shumway NE. Independent determinants of operative mortality for patients with aortic dissections. Circulation 1984;70(Suppl 1):153–64.
  9. Crawford ES, Svensson LG, Coselli JS, Safi HJ, Hess KR. Aortic dissection and dissecting aortic aneurysms. Ann Surg 1988;208:254–73.[Medline]
  10. Wheat MW Jr. Acute dissection of the aorta. Cardiovasc Clin 1987;17:241–62.[Medline]
  11. Wheat MW Jr. Current status of medical therapy of acute dissecting aneurysms of the aorta. World J Surg 1980;4:563–9.[Medline]
  12. Reul GJ, Cooley DA, Hallman GL, Reddy SB, Kyger III ER, Wukasch DC. Dissecting aneurysm of the descending aorta: improved surgical results in 91 patients. Arch Surg 1975;110:632–40.[Abstract]
  13. Trent MS, Parsonnet V, Shoenfeld R, et al. A balloon-expandable intravascular stent for obliterating experimental aortic dissection. J Vasc Surg 1990;11:707–17.[Medline]
  14. Moon MR, Dake MD, Pelc LR, et al. Intravascular stenting of acute experimental type B dissections. J Surg Res 1993;54:381–8.[Medline]
  15. Kawashima Y, Shirakura R, Nakano S, et al. Long-term results of entry closure and aneurysmal wall plication with axillofemoral bypass: a new procedure for repair of DeBakey type III dissecting aneurysm. Surgery 1993;113:59–64.[Medline]
  16. Dotter CT. Transluminally-placed coilsprings endarterial tube graft: long-term patency in the canine popliteal artery. Intest Radiol 1969;4:329–32.
  17. Wright KC, Wallace S, Charnsangavej C, Carrasco CH, Gianturco C. Percutaneous endovascular stent: an experimental evaluation. Radiology 1985;156:69–72.[Abstract/Free Full Text]
  18. Palmaz JC, Sibitt RR, Reuter SR, Tio FO, Rice WJ. Expandable intraluminal graft: a preliminary study. Radiology 1985;156:73–7.[Abstract/Free Full Text]
  19. Rosch J, Uchida BT, Putnam JS, Buschman RW, Law RD, Hershey AL. Experimental intrahepatic portacaval anastomosis: use of expandable Gianturco stents. Radiology 1987;162:481–5.[Abstract/Free Full Text]
  20. Akaba N, Ujiie H, Umezawa K, et al. Management of acute aortic dissections with a cylinder-type balloon catheter to close the entry. J Vasc Surg 1986;3:890–4.[Medline]



This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
K. Shimamura, T. Kuratani, G. Matsumiya, M. Kato, Y. Shirakawa, H. Takano, N. Ohta, and Y. Sawa
Long-term results of the open stent-grafting technique for extended aortic arch disease.
J. Thorac. Cardiovasc. Surg., June 1, 2008; 135(6): 1261 - 1269.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
S.-G. Kang, D. Y. Lee, M. Maeda, E. S. Kim, D. Choi, B.-O. Kim, H. K. Yoon, K. B. Sung, and H.-Y. Song
Aortic Dissection: Percutaneous Management with a Separating Stent-Graft—Preliminary Results
Radiology, August 1, 2001; 220(2): 533 - 539.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
B. V. Czermak, P. Waldenberger, G. Fraedrich, A. H. Dessl, K. E. Roberts, R. J. Bale, R. Perkmann, and W. R. Jaschke
Treatment of Stanford Type B Aortic Dissection with Stent-Grafts: Preliminary Results
Radiology, November 1, 2000; 217(2): 544 - 550.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
T. Ohata, T. Sakakibara, H. Takano, H. Izutani, and Y. Inoue
Rapid enlargement of a distal arch aneurysm after endovascular stent-grafting for pseudoaneurysm: Case report
J. Thorac. Cardiovasc. Surg., October 1, 2000; 120(4): 824 - 826.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
B. J. d’Othee, H. Rousseau, P. Soula, B. Dongay, M. I. Millan, M. Galinier, P. Massabuau, F. Joffre, and P. Otal
AORTIC STENT GRAFTING AND SIDE-BRANCH EMBOLIZATION IN AN EXPANDING CHRONIC TYPE B DISSECTION
J. Thorac. Cardiovasc. Surg., December 1, 1999; 118(6): 1021 - 1025.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. Ezure, Y. Kotsuka, A. Furuse, M. Kawauchi, T. Kohno, and H. Kubota
Repair of Ruptured Anastomotic Aneurysm: Elephant Trunk Technique After Endovascular Covered Stents
Ann. Thorac. Surg., January 1, 1998; 65(1): 241 - 241.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Kato, H.-z. Bai, K. Sato, S. Kawamoto, M. Kaneko, T. Ueda, D. Kishi, and K. Ohnishi
Determining Surgical Indications for Acute Type B Dissection Based on Enlargement of Aortic Diameter During the Chronic Phase
Circulation, November 1, 1995; 92(9): 107 - 112.
[Abstract] [Full Text]


This Article
Right arrow Abstract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Masaaki Kato
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kato, M.
Right arrow Articles by Ohnishi, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kato, M.
Right arrow Articles by Ohnishi, K.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS